PROMIS PF10a1,2
Measure
Information
Developed by the NIH to standardise physical health measurement in chronic conditions
Length
10 questions
Topics
Link
Score
0 (low disability) – 100 (high disability)
Attributes
HAQ-II1,3,4
Measure
Information
Developed to assess functional status in rheumatic disease and designed to be short with reduced floor effects
Length
10 questions
Topics
Link
Score
0 (low disability) – 3 (high disability)
Attributes
MDHAQ1,3,4
Measure
Information
Derived from the HAQ to measure functional status with a shorter time commitment and designed to be sensitive to changes at the low end of the scale
Length
10 questions
Topics
Link
Score
0 (low disability) – 3 (high disability)
Attributes
ACR, American College of Rheumatologists; HAQ, Health Assessment Questionnaire; HAQ-II, Health Assessment Questionnaire II; MDHAQ, Multidimensional Health Assessment Questionnaire; M-HAQ, Modified Health Assessment Questionnaire; NIH, National Institutes of Health; PROMIS, Patient-Reported Outcomes Measurement Information System; PROMIS PF10a, Patient-Reported Outcomes Measurement Information System Physical Function 10-Item Short Form; QoL, quality of life; RA, rheumatoid arthritis.
REFERENCES
1. Barber CEH, Zell J, Yazdany J, et al. Arthritis Care Res (Hoboken). 2019;71(12):1531-1539. 2. Bartlett SJ, Orbai AM, Duncan T, et al. PLoS One. 2015;10(9):e0138543. 3. Maska L, Anderson J, Michaud K. Arthritis Care Res (Hoboken). 2011;63 Suppl 11:S4-S13. 4. Health Assessment Questionnaires (HAQ, HAQ-II, MDHAQ). RheumInfo. Accessed March 3, 2021. https://rheuminfo.com/physician-tools/health-assessment-questionnaires-haq-haq-ii-mdhaq/
GALAPAGOS and the GALAPAGOS logo are registered or pending trademarks of Galapagos
NV.
© Galapagos Biopharma Sweden AB.
Vasagatan 7, 101 23 Stockholm, Sweden, VAT: SE559311454801. All rights reserved.
SE-RA-JY-202203-00001
© Copyright 2021 Galapagos NV
You are about to leave this website and will be redirected to an external website. We are not responsible of that external website’s content. By continuing, you confirm that you have taken note of this.